ARWR   $56.33  -1.11% Market Closed After Close 57.1826 1.51%

Arrowhead Pharmaceuticals, Inc.
Total Cash 434.47M
totalCashPerShare 3.495
EBITDA -529.78M
Total Debt 454.12M
quickRatio 4.492
currentRatio 4.654
Total Revenue 19.65M
debtToEquity 133.97
Revenue/Share 0.17
ROA -0.40724
ROE -1.51843
grossProfits
freeCashflow -413.91M
operatingCashflow -351.56M
earningsGrowth
revenueGrowth
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -27.85052
profitMargins 0.0
enterpriseValue 2.68B
forwardPE -5.0568724
floatShares 110.49M
sharesOutstanding 124.31M
sharesShort 9.33M
sharesShortPriorMonth 9.05M
dateShortInterest
sharesPercentSharesOut 0.08%
heldPercentInsiders 0.04%
heldPercentInstitutions 0.80%
Short Ratio help_outline 8.12%
shortPercentOfFloat 0.09%
impliedSharesOutstanding
bookValue 2.661
Price To Book help_outline 8.02
earningsQuarterlyGrowth
netIncomeToCommon -538.64M
trailingEps -4.82%
forwardEps -4.22%
enterpriseToEbitda -5.06
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.05 3Q 2024
institutionsCount 366
lastUpdated Nov. 7, 2024, 9:19 a.m.